Current Status on Management of Primary Plasma Cell Leukemia.
Current Oncology Reports（2024）
Abstract
Plasma Cell Leukemia (PCL) is a very rare and highly aggressive form of plasma cell dyscrasia. This review seeks to evaluate the outcomes of PCL in the context of combination novel agent therapy and stem cell transplant (SCT) protocols. The diagnostic criteria for PCL have now evolved to include patients with 5
MoreTranslated text
Key words
Novel agents,Stem cell transplant,PCL
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined